http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102214378-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-602 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 |
| filingDate | 2020-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102214378-B1 |
| titleOfInvention | Composition for skin cell regeneration, anti-wrinkle, anti-inflammation, or skin whitening |
| abstract | The present invention relates to a composition for skin regeneration, wrinkle improvement, anti-inflammatory or skin whitening. Companatoside A according to the present invention increases the total amount of collagen in fibroblasts of the skin, inhibits collagenase activity, enhances skin regeneration or wrinkle improvement, and inhibits nitric oxide production, thereby anti-inflammatory effect. It represents a whitening effect by reducing the total amount of melanin, so it can be used as a pharmaceutical composition, an external preparation for skin, a cosmetic composition or a health food. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220169510-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4104842-A1 |
| priorityDate | 2013-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 214.